Itopride as a Potential Drug Against Cancer (Breast and Prostate), by Repurposing Determined Through AI

José Luis Vique-Sánchez1, Ana Brenda Ortega Morales1

  • 1School of Medicine and Nutrition, Autonomous University of Baja California, Mexicali, Baja California, México.

Insights

Artificial intelligence identified Itopride, a drug for dyspepsia, as a potential cancer treatment. In silico and in vitro studies show Itopride has antiproliferative effects against prostate and breast cancer cells.

Area of Science:

  • Oncology
  • Pharmacology
  • Artificial Intelligence in Medicine

Background:

  • Breast and prostate cancer are leading causes of cancer incidence and mortality globally.
  • There is a continuous need for novel therapeutic strategies and drug options to combat cancer.
  • Drug repurposing, accelerated by artificial intelligence (AI), offers a promising avenue for identifying new cancer treatments.

Purpose of the Study:

  • To investigate the potential of the repurposed drug Itopride as an antiproliferative agent against cancer.
  • To explore the efficacy of Itopride as an adjuvant therapy for prostate and breast cancer.

Main Methods:

  • Utilized artificial intelligence (AI) for drug repurposing to identify potential anticancer agents.
  • Conducted in silico (computational) and in vitro (laboratory) assays to evaluate the antiproliferative effects of Itopride.

Main Results:

  • Itopride demonstrated significant cytotoxic and antiproliferative effects in vitro cancer cell cultures.
  • AI-driven drug repurposing identified Itopride as a potential candidate for cancer therapy.

Conclusions:

  • Itopride exhibits potential as an antiproliferative agent and can be considered a potential adjuvant therapy for prostate and breast cancer.
  • The study highlights the successful application of AI and drug repurposing in discovering novel therapeutic applications for existing drugs.

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...